Page last updated: 2024-08-23

moxalactam and e 5531

moxalactam has been researched along with e 5531 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Asano, O; Christ, WJ; Dubuc, GR; Gavin, WE; Hawkins, LD; McGuinness, PD; Mullarkey, MA; Perez, M; Robidoux, AL; Wang, Y	1

Other Studies

1 other study(ies) available for moxalactam and e 5531

Article	Year
E5531, a pure endotoxin antagonist of high potency. Science (New York, N.Y.), 1995, Apr-07, Volume: 268, Issue:5207 Topics: Animals; BCG Vaccine; Cytokines; Drug Design; Endotoxins; Escherichia coli Infections; Gram-Negative Bacteria; Humans; In Vitro Techniques; Lipid A; Lipopolysaccharides; Macrophages; Male; Mice; Mice, Inbred C57BL; Monocytes; Moxalactam; Nitric Oxide; Rhodobacter capsulatus; Tumor Necrosis Factor-alpha	1995

Article

Year

E5531, a pure endotoxin antagonist of high potency.

Science (New York, N.Y.), 1995, Apr-07, Volume: 268, Issue:5207

Topics: Animals; BCG Vaccine; Cytokines; Drug Design; Endotoxins; Escherichia coli Infections; Gram-Negative Bacteria; Humans; In Vitro Techniques; Lipid A; Lipopolysaccharides; Macrophages; Male; Mice; Mice, Inbred C57BL; Monocytes; Moxalactam; Nitric Oxide; Rhodobacter capsulatus; Tumor Necrosis Factor-alpha

1995